Delivering Therapy for Hepatitis C Virus Infection to Incarcerated HIV‐Seropositive Patients (original) (raw)
Comparison of hepatitis C virus treatment between incarcerated and community patients
Rob Striker
Hepatology, 2012
View PDFchevron_right
Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison
Jake Rance
Journal of Viral Hepatitis, 2018
View PDFchevron_right
Access to Treatment of Hepatitis C in Prison Inmates
J. Mossong, Vic Arendt
Digestive Diseases and Sciences, 2009
View PDFchevron_right
Hepatitis C Viral Infection in Prisons
Amber Arain
View PDFchevron_right
Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting
Jake Rance
International Journal of Drug Policy, 2020
View PDFchevron_right
Linkage to Hepatitis C Care After Incarceration in Jail: A Prospective, Single Arm Clinical Trial
Matthew J Akiyama
View PDFchevron_right
Impact of new therapeutics for hepatitis C virus infection in incarcerated populations
Jeff Dickert
Topics in antiviral medicine, 2013
View PDFchevron_right
Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework
Prem Thurairajah
The Lancet Gastroenterology & Hepatology, 2021
View PDFchevron_right
Feasibility of Treating Hepatitis C in a Transient Jail Population
Matthew J Akiyama
Open Forum Infectious Diseases
View PDFchevron_right
Linkage to Hepatitis C Care Following Release from Jail: A Prospective, Single Arm Clinical Trial
Alison Jordan
2019
View PDFchevron_right
Continuum of Hepatitis C Care Cascade in Prison and Following Release in the Direct-acting Antivirals Era
Ramin Alasvand
View PDFchevron_right
A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy
J. Tomnay
Journal of Viral Hepatitis, 2016
View PDFchevron_right
Acute Hepatitis C Virus Infection in Incarcerated Injection Drug Users
Ioana Bica
Clinical Infectious Diseases, 2006
View PDFchevron_right
Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs
Jesse Young
2014
View PDFchevron_right
‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures
Jake Rance
Drugs-education Prevention and Policy, 2018
View PDFchevron_right
Hepatitis C in correctional institutions
Nickolas Zaller, Josiah Rich
Current Hepatitis Reports, 2007
View PDFchevron_right
Outcomes of Hepatitis C Virus Treatment in the New York City Jail Population: Successes and Challenges Facing Scale up of Care
Matthew J Akiyama
Open Forum Infectious Diseases
View PDFchevron_right
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users
Brian Edlin
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005
View PDFchevron_right
The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care
Emma Gill
Health & justice, 2017
View PDFchevron_right
Increasing Hepatitis C Prevalence and Associated Risk Behaviors among Incarcerated Young Adults
phyllis losikoff
Journal of Urban Health, 2013
View PDFchevron_right
The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
yu jun wong
Clinical and Molecular Hepatology, 2021
View PDFchevron_right
Reasons for not initating hcv treatment in prison: a sub-analysis of the epiband study
Joaquín De Juan
2011
View PDFchevron_right
Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project
Sofia Bartlett
Clinical Infectious Diseases
View PDFchevron_right
Hepatitis C Micro-Elimination beyond Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences
Javier Crespo
Diagnostics, 2021
View PDFchevron_right
Hepatitis C in State Correctional Facilities
Josiah Rich
Preventive Medicine, 1999
View PDFchevron_right
Hepatitis C in the criminal justice system: opportunities for global action in the era of viral hepatitis elimination
Matthew J Akiyama
BMC Medicine
View PDFchevron_right
Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct‐Acting Antiviral Era
Camila Picchio
Clinical Liver Disease, 2021
View PDFchevron_right
Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention
Keith Sabin
AIDS, 2005
View PDFchevron_right
Prisoners favour hepatitis C testing and treatment
Snigdha Vallabhaneni
Epidemiology and Infection, 2006
View PDFchevron_right
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study
tony gerard Butler
The Lancet Gastroenterology & Hepatology, 2021
View PDFchevron_right
Treatment of Chronic Hepatitis C Virus in the Virginia Department of Corrections: Can Compliance Overcome Racial Differences to Response?
Mitchell Shiffman
The American Journal of Gastroenterology, 2004
View PDFchevron_right
Prevalence Of HIV, Syphilis, Hepatitis B, and Hepatitis C Among Entrants to Maryland Correctional Facilities
Liza Solomon
Journal of Urban Health: Bulletin of the New York Academy of Medicine, 2004
View PDFchevron_right